Knowledge and application of sonographic scoring models for ovarian cancer management among gynecologists in Saudi Arabia: a cross-sectional study
- PMID: 40755791
- PMCID: PMC12315828
- DOI: 10.7717/peerj.19746
Knowledge and application of sonographic scoring models for ovarian cancer management among gynecologists in Saudi Arabia: a cross-sectional study
Abstract
Background: Ovarian cancer is a significant global health concern, ranking as the seventh most common cancer and the eighth leading cause of cancer-related deaths among women. Annually, it claims the lives of approximately 207,000 women worldwide. Early detection is crucial, as most cases are diagnosed at advanced stages, resulting in a 5-year survival rate of less than 20%. Common diagnostic tools include Cancer Antigen 125 (CA125) and ultrasound, but these methods are limited by sensitivity, specificity, and operator dependence. The Risk of Malignancy Index (RMI) and the Assessment of Different NEoplasias in the Adnexa (ADNEX) model, which integrates ultrasound and CA125, offer improved diagnostic accuracy. This study aims to assess the knowledge and application of these models among gynecologists in Saudi Arabia.
Methods: A cross-sectional study was conducted involving 148 gynecologists from various hospitals in Saudi Arabia. Participants completed a structured questionnaire that was distributed online, designed to evaluate their knowledge and application of the RMI and ADNEX models. Data were analyzed using descriptive statistics, and factors influencing the utilization of these models were identified through multivariate logistic regression analysis.
Results: The study found that 72% of the gynecologists were familiar with the RMI, and 58% were aware of the ADNEX model. However, only 46% reported regularly using the RMI, and 32% used the ADNEX model in their practice. Key barriers to the application of these models included a lack of training (56%), and limited access to necessary diagnostic tools (48%). Gynecologists with more than 10 years of experience were significantly more likely to use the RMI (odds ratio (OR): 2.5, 95% confidence interval (CI) [1.3-4.8]) and the ADNEX model (OR: 2.1, 95% CI [1.1-4.0]).
Conclusion: In Saudi Arabia, gynecologists show moderate knowledge of sonographic scoring models for ovarian cancer management, with higher familiarity for RMI than ADNEX. However, application in clinical practice is limited. Experience level influences usage, while lack of training and diagnostic access remain key barriers. Targeted educational efforts and improved resource availability are needed to support broader clinical adoption.
Keywords: ADNEX model; Clinical decision-making; Gynecology; Ovarian cancer; Risk of malignancy index (RMI); Sonographic scoring.
© 2025 Aldahlawi.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Menopausal status, ultrasound and biomarker tests in combination for the diagnosis of ovarian cancer in symptomatic women.Cochrane Database Syst Rev. 2022 Jul 26;7(7):CD011964. doi: 10.1002/14651858.CD011964.pub2. Cochrane Database Syst Rev. 2022. PMID: 35879201 Free PMC article.
-
Risk scores to guide referral decisions for people with suspected ovarian cancer in secondary care: a systematic review and cost-effectiveness analysis.Health Technol Assess. 2018 Aug;22(44):1-264. doi: 10.3310/hta22440. Health Technol Assess. 2018. PMID: 30165935 Free PMC article.
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article.
-
Sexual Harassment and Prevention Training.2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 36508513 Free Books & Documents.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
References
-
- Araujo KG, Jales RM, Pereira PN, Yoshida A, de Angelo Andrade L, Sarian LO, Derchain S. Performance of the IOTA ADNEX model in preoperative discrimination of adnexal masses in a gynecological oncology center. Ultrasound in Obstetrics & Gynecology. 2017;49(6):778–783. doi: 10.1002/uog.15963. - DOI - PubMed
-
- Buranaworathitikul P, Wisanumahimachai V, Phoblap N, Porngasemsart Y, Rugfoong W, Yotchana N, Uthaichalanont P, Jiampochaman T, Kunanukulwatana C, Thiamkaew A, Luewan S, Tantipalakorn C, Tongsong T. Accuracy of O-RADS system in differentiating between benign and malignant adnexal masses assessed via external validation by inexperienced gynecologists. Cancers. 2024;16(22):3820. doi: 10.3390/cancers16223820. - DOI - PMC - PubMed
-
- Epstein E, Van Calster B, Timmerman D, Nikman S. Subjective ultrasound assessment, the ADNEX model and ultrasound-guided tru-cut biopsy to differentiate disseminated primary ovarian cancer from metastatic non-ovarian cancer. Ultrasound in Obstetrics & Gynecology. 2016;47(1):110–116. doi: 10.1002/uog.14892. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous